Massmutual Trust CO Fsb Bluebird Bio, Inc. Transaction History

Massmutual Trust CO Fsb

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$2.94 - $5.23 $1,178 - $2,097	-401 Closed	0 $0
Q1 2022 Apr 08, 2022	BUY	$4.07 - $10.6 $1,632 - $4,250	401 New	401 $2,000
Q3 2021 Nov 12, 2021	SELL	$11.24 - $21.0 $337 - $630	-30 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.04 - $22.09 $541 - $662	30 New	30 $1,000
Q1 2018 May 21, 2018	SELL	$105.8 - $150.94 $529 - $754	-5 Closed	0 $0
Q4 2017 Mar 01, 2018	BUY	$81.25 - $130.7 $406 - $653	5	5 $891,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.